journal article·2026-05

Promoting DNA alkylation of hypoxia-activated molecular prodrug for cooperative precision photodynamic-chemotherapy

Yang Zou, Xinmeng Yu, Manqing Wu, Shuang E, Yang Xuan, Yinan Zhao, Jiangli Fan, Shubiao Zhang

Dyes and Pigments· Volume 248
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer, Hypoxia, and Metabolism · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (45)

Show source-provided references
1. Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer10.1038/s41586-022-04508-4 ↗
2. Paradoxical effects of DNA tumor virus oncogenes on epithelium-derived tumor cell fate during tumor progression and chemotherapy response10.1038/s41392-021-00787-x ↗
3. Balancing repair and tolerance of DNA damage caused by alkylating agents10.1038/nrc3185 ↗
4. Reactive OFF-ON type alkylating agents for higher-ordered structures of nucleic acids10.1093/nar/gkz512 ↗
5. Electrochemistry of chemo-therapeutic alkylating agents and their interaction with DNA10.1016/j.jpba.2022.115036 ↗
6. Chemotherapy: a double-edged sword in cancer treatment10.1007/s00262-021-03013-3 ↗
7. Supramolecular chemotherapy based on host-guest molecular recognition: a novel strategy in the battle against cancer with a bright future10.1039/C6CS00898D ↗
8. Molecular interactions in organic nanoparticles for phototheranostic applications10.1021/acs.chemrev.5b00140 ↗
9. Liu W., He S., Ma X., Lv C., Gu H., Cao J., Du J., Sun W., Fan J., Peng X. Near-infrared heptamethine cyanine photosensitizers with efficient singlet oxygen generation for anticancer photodynamic therapy. Angew Chem Int Ed 2024;63:e202411802. doi:10.1002/anie.202411802.10.1002/anie.202411802 ↗
10. Single-molecule förster resonance energy transfer-based photosensitizer for synergistic photodynamic/photothermal therapy10.1021/acscentsci.0c01551 ↗
11. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application10.1039/D0CS00173B ↗
12. Supramolecular photosensitizer enables oxygen-independent generation of hydroxyl radicals for photodynamic therapy10.1021/jacs.2c11868 ↗
13. Recent advancement in photosensitizers for photodynamic therapy10.1016/j.dyepig.2024.112262 ↗
14. Carrier-free, amorphous verteporfin nanodrug for enhanced photodynamic cancer therapy and brain drug delivery10.1002/advs.202302872 ↗
15. A photosensitizer-inhibitor conjugate for photodynamic therapy with simultaneous inhibition of treatment escape pathways10.1016/j.biomaterials.2020.120262 ↗
16. Structure-inherent targeting of near-infrared fluorophores for parathyroid and thyroid gland imaging10.1038/nm.3728 ↗
17. De novo design of phototheranostic sensitizers based on structure-inherent targeting for enhanced cancer ablation10.1021/jacs.8b09117 ↗
18. A single molecule drug targeting photosensitizer for enhanced breast cancer photothermal therapy10.1002/smll.201907677 ↗
19. Photosensitizers with aggregation‐induced emission: materials and biomedical applications10.1002/adma.201801350 ↗
20. Self-assembled core-shell nanoparticles for combined chemotherapy and photodynamic therapy of resistant head and neck cancers10.1021/nn506963h ↗
21. Nucleus-targeting near-infrared nanoparticles based on TAT peptide-conjugated IR780 for photo-chemotherapy of breast cancer10.1016/j.cej.2019.122458 ↗
22. ROS-responsive camptothecin prodrug nanoparticles for on-demand drug release and combination of chemotherapy and photodynamic therapy10.1002/adfm.202005918 ↗
23. Manganese/iron-based nanoprobes for photodynamic/chemotherapy combination therapy of tumor guided by multimodal imaging10.1039/D0NR08831E ↗
24. Phase-change mediated intelligent nanoplatform for chemo/photothermal/photodynamic therapy of cancer10.1002/adhm.202202245 ↗
25. The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy10.1039/D2CS00673A ↗
26. Redox-programmed theranostic system with instant response: light-triggered methylene blue activation driving self-amplified PDT through glutathione depletion and synergistic chemotherapy10.1016/j.dyepig.2025.112997 ↗
27. Hypoxia-targeted drug delivery10.1039/C8CS00304A ↗
28. Nanomaterials relieving hypoxia for enhanced tumor therapy10.1016/j.ccr.2023.215482 ↗
29. Enhancing the release efficiency of a molecular chemotherapeutic prodrug by photodynamic therapy10.1002/anie.202206169 ↗
30. Near-infrared fluorescent probes for hypoxia detection via joint regulated enzymes: design, synthesis, and application in living cells and mice10.1021/acs.analchem.8b04249 ↗
31. Recent development of chemosensors based on cyanine platforms10.1021/acs.chemrev.6b00001 ↗
32. Design strategies and applications of cyanine dyes in phototherapy10.1039/D3CS00585B ↗
33. Regulating charge transfer in cyanine dyes: a universal methodology for enhancing cancer phototherapeutic efficacy10.1021/acs.accounts.4c00399 ↗
34. Hypoxia-activated NIR photosensitizer anchoring in the mitochondria for photodynamic therapy10.1039/C9SC03355F ↗
35. The nitrogen mustards10.1124/pharmrev.120.000121 ↗
36. H-aggregates of prodrug-hemicyanine conjugate for enhanced photothermal therapy and sequential hypoxia-activated chemotherapy10.1021/acsmaterialslett.2c00015 ↗
37. Hypoxia-activatable nano-prodrug for fluorescently tracking drug release in mice10.1007/s11426-020-9880-7 ↗
38. NIR photo-sensitizers activated by γ-glutamyl transpeptidase for precise tumor fluorescence imaging and photodynamic therapy10.1007/s11426-020-9947-4 ↗
39. Injectable and sprayable fluorescent nanoprobe for rapid real-time detection of human colorectal tumors
40. Thermoresponsive chlorambucil derivatives for tumour targeting10.1002/anie.201101133 ↗
41. Functional up-grading of an organo-Ir(III) complex to an organo-Ir(III) prodrug as a DNA damage-responsive autophagic inducer for hypoxic lung cancer therapy10.1021/acs.inorgchem.4c00060 ↗
42. Heat induces γH2AX foci formation in mammalian cells10.1016/j.mrgentox.2008.07.012 ↗
43. ROS-responsive mitochondria-targeting blended nanoparticles: chemo- and photodynamic synergistic therapy for lung cancer with on-demand drug release upon irradiation with a single light source10.7150/thno.15433 ↗
44. Heptamethine cyanine-based molecule release triggered by mitochondrial ROS10.1021/acsabm.3c00955 ↗
45. Photodynamic therapy-triggered on-demand drug release from ROS-responsive core-cross-linked micelles toward synergistic anti-cancer treatment10.1007/s12274-019-2330-y ↗